Author: De Jong, Cornelis N.; Saes, Lotte; Klerk, Clara P. W.; Van der Klift, Marjolein; Cornelissen, Jan J.; Broers, Annoek E. C.
Title: Etanercept for steroid-refractory acute graft-versus-host disease: A single center experience Document date: 2017_10_26
ID: 1hcp36cw_22
Snippet: Clinically significant infectious complications (CTC-AE grade !3 or grade 2 requiring systemic treatment) occurred in 13 patients (87%), including bacterial sepsis in 9 patients (60%), viral infections in 8 patients (53%; including CMV and EBV reactivation, BK virus, rhinovirus, and coronavirus), and invasive pulmonary aspergillosis in 3 patients (20%). One patient experienced a seizure, which was attributed to CsA, rather than etanercept. Infect.....
Document: Clinically significant infectious complications (CTC-AE grade !3 or grade 2 requiring systemic treatment) occurred in 13 patients (87%), including bacterial sepsis in 9 patients (60%), viral infections in 8 patients (53%; including CMV and EBV reactivation, BK virus, rhinovirus, and coronavirus), and invasive pulmonary aspergillosis in 3 patients (20%). One patient experienced a seizure, which was attributed to CsA, rather than etanercept. Infectious complications are shown in Table 4 .
Search related documents:
Co phrase search for related documents- bacterial sepsis and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
- BK virus and infectious complication: 1
- BK virus and pulmonary aspergillosis: 1
- BK virus and systemic treatment: 1
- BK virus and viral infection: 1, 2, 3, 4, 5
- EBV CMV reactivation and viral infection: 1
- infectious complication and pulmonary aspergillosis: 1
- infectious complication and viral infection: 1, 2
- pulmonary aspergillosis and viral infection: 1, 2, 3, 4, 5, 6, 7, 8
- systemic treatment and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- systemic treatment require and viral infection: 1
Co phrase search for related documents, hyperlinks ordered by date